Table 1 Patient demographic details
Age | Gender | Time since diagnosis (months) | Time since commencing adalimumab (months) | Ocular complications | Active joint count at time of review | Uveitis activity at time of review * |
|---|---|---|---|---|---|---|
6 | F | 37 | 24 | Nil | 0 | Right 0 Left 0 |
8 | F | 72 | 13 | Nil | 0 | Right 2+ Left 2+ |
10 | M | 66 | 58 | Cataract, posterior synechiae, ocular hypertension | 0 | Right 0.5+ Left 0.5+ |
11 | F | 82 | 27 | Nil | 1 | Right 0.5+ Left 0.5+ |
12 | M | 43 | 25 | Cataract | 0 | Right 0.5+ Left 0.5+ |
12 | F | 127 | 80 | Posterior synechiae | 0 | Right 0 Left 0 |
13 | M | 143 | 122 | Cataract, posterior synechiae, band keratopathy | 0 | Right 0 Left 0.5+ |
15 | F | 172 | 21 | Nil | 0 | Right 0.5+ Left 0.5+ |
17 | F | 190 | 59 | Nil | 0 | Right 0.5+ Left 0.5+ |